Moreover, our findings that RBMS1 expression positively correlates with lung cancer metastatic progression and RBMS1 knockdown attenuates tumor metastasis, suggest that RBMS1 may represent an attractive anti‐metastatic target for lung cancer treatment. The gene discussed is RBMS1; the disease is neoplasm.